Biological effects of aromatic bis[aminomethylidenebis(phosphonic)] acids in osteoclast precursors in vitro
作者:Anna Nasulewicz‐Goldeman、Waldemar Goldeman、Ewa Mrówczyńska、Joanna Wietrzyk
DOI:10.1111/cbdd.13597
日期:2019.10
bone resorption by preventing osteoclast activity. Most clinically used BPs are hydroxybisphosphonates with the exception of incadronate, which belongs to the class of aminomethylidenebisphosphonic acids. The aim of this study was to evaluate the antiproliferative activity of two previously reported aminobisphosphonates (WG8185B2 and WG9001B) in combination with doxorubicin and cisplatin toward J774E
含氮的双膦酸盐(N-BPs)通过阻止破骨细胞活性来抑制骨吸收。临床上大多数使用的BP是羟基双膦酸酯,但硬脂酸酯除外,其属于氨基亚甲基双膦酸类。这项研究的目的是评估两种先前报道的氨基双膦酸盐(WG8185B2和WG9001B)与阿霉素和顺铂联合对J774E细胞(体外破骨细胞前体模型)的抗增殖活性。WG8185B2和WG9001B BP增强了阿霉素和顺铂的细胞毒活性,尤其是在细胞抑制药前24小时使用时。研究的BPs的抗增殖作用与细胞周期进程的变化有关。WG8185B2导致S期的J774E细胞大量积聚,WG9001B导致G2 / M期的短暂停滞,随后S期的细胞百分比增加。此外,WG8185B2和WG9001B BP在破骨细胞前体中显示出增强的促凋亡活性,这通过caspase-3活性和凋亡细胞百分数的增加来体现。另外,两种化合物都影响J774E细胞的运动性。所检查的BP的确切分子作用机理尚待确定;